professorThe Affiliated Hospital of Xuzhou Medical College, Jiangsu, P.R. ChinaXuzhou, Jiangsu, China (People's Republic)
OC 21.5 - An Open-label,Dose-Escalation,Multicenter Phase I Study to Evaluate the Safety,Immunogenicity,and Pharmacokinetics/pharmacodynamics（PK/PD）of Single Dose SS109 in Hemophilia A/B patients with Inhibitor
Sunday, June 23, 202415:45 – 16:00 ICT
OC 40.1 - A Novel Extended half-life factor VIII Fc fusion protein FRSW107 for severe hemophilia A: A multicentre, open-label, single-arm, phase 3 study and its open-label extension
Monday, June 24, 202414:45 – 15:00 ICT
